CARM1 and breast cancer: Using quantitative mass spectrometry along with pan-specific ADMA antibodies, we comprehensively profiled substrates of CARM1, the prototype PRMT with the strongest link to oncogenesis5, 6, 12, in two breast cancer cell lines.